Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21882318 | 0.80 | THRB (0.32) | THRBLMNA | |
| SCHEMBL23896835 | 0.72 | THRB (0.31) | THRBLMNA | |
| SCHEMBL220519 | 0.71 | MAPT (0.53) | THRBLMNA | |
| SCHEMBL8283547 | 0.71 | THRB (0.44) | THRBLMNA | |
| SCHEMBL19477926 | 0.67 | ATP1A1 (0.31) | — | |
| SCHEMBL20912079 | 0.66 | THRB (0.54) | THRBLMNA | |
| SCHEMBL21097627 | 0.66 | THRB (0.54) | THRBLMNA | |
| SCHEMBL24137980 | 0.66 | THRB (0.54) | THRBLMNA | |
| SCHEMBL18959379 | 0.66 | THRB (0.54) | THRBLMNA | |
| SCHEMBL1897888 | 0.66 | THRB (0.54) | THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220017566-A1 | TERPINOID DERIVATIVES AND USES THEREOF | FRONTHERA U.S. PHARMACEUTICALS LLC | 2022-01-20 | — | — | US | disclosed |
| WO-2020068689-A1 | TERPINOID DERIVATIVES AND USES THEREOF | FRONTHERA U.S. PHARMACEUTICALS LLC (US) | 2020-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220017566-A1 | TERPINOID DERIVATIVES AND USES THEREOF | KEAP1, PTGES, GSTK1 | THRB 453/4885LMNA 2033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.